PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Chemical Biology & Drug Design10.1111/cbdd.120852012811113-121Antibody-Drug Conjugates for the Treatment of CancerJohn A. Flygare, Thomas H. Pillow, Paul Aristoffhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcbdd.12085, http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12085/fullpdf
Clinical Genitourinary Cancer10.1016/j.clgc.2020.11.0062020The Evolving Landscape of Antibody–Drug Conjugates for Urothelial CarcinomaMelissa Abel, Aaron Burkenroad, Alexander Sun, Eric Lu, Dimitrios Stefanoudakis, Alexandra Drakakihttps://api.elsevier.com/content/article/PII:S1558767320302676?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1558767320302676?httpAccept=text/plain
The Korean Journal of Urological Oncology10.22465/kjuo.2021.19.1.30202119130-39The Development of Antibody-Drug Conjugates for Urothelial Carcinoma TreatmentDa Som Choi, Su Jeong Kang, In Ho Chang, Young Wook Choihttp://kjuo.or.kr/upload/pdf/kjuo-19-1-30.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2021.19.1.30, http://kjuo.or.kr/upload/pdf/kjuo-19-1-30.pdf
Current Oncology Reports10.1007/s11912-020-0879-y2020222Antibody-Drug Conjugates in Urothelial CarcinomasMichal Sarfaty, Jonathan E. Rosenberghttp://link.springer.com/content/pdf/10.1007/s11912-020-0879-y.pdf, http://link.springer.com/article/10.1007/s11912-020-0879-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11912-020-0879-y.pdf
Antibody-Drug Conjugates and Immunotoxins10.1007/978-1-4614-5456-4_4201257-75Clinical Pharmacology Strategies in the Development of Antibody–Drug ConjugatesSandhya Girish, Manish Guptahttp://link.springer.com/content/pdf/10.1007/978-1-4614-5456-4_4
Innovations for Next-Generation Antibody-Drug Conjugates10.1007/978-3-319-78154-9_112018267-280Bispecific and Biparatopic Antibody Drug ConjugatesFrank Comer, Changshou Gao, Steve Coatshttp://link.springer.com/content/pdf/10.1007/978-3-319-78154-9_11
Innovations for Next-Generation Antibody-Drug Conjugates10.1007/978-3-319-78154-9_102018241-265Site-Specific Antibody-Drug ConjugatesFeng Tian, Dowdy Jackson, Yun Baihttp://link.springer.com/content/pdf/10.1007/978-3-319-78154-9_10
Innovations for Next-Generation Antibody-Drug Conjugates10.1007/978-3-319-78154-9_132018299-319Antibody-Drug Conjugates: Targeting the Tumor MicroenvironmentAlberto Dal Corso, Samuele Cazzamalli, Dario Nerihttp://link.springer.com/content/pdf/10.1007/978-3-319-78154-9_13
Innovations for Next-Generation Antibody-Drug Conjugates10.1007/978-3-319-78154-9_122018281-298Targeting Drug Conjugates to the Tumor Microenvironment: Probody Drug ConjugatesJack Lin, Jason Sagerthttp://link.springer.com/content/pdf/10.1007/978-3-319-78154-9_12
Molecules10.3390/molecules25122861202025122861Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery PerspectiveDavid Dahlgren, Hans Lennernäshttps://www.mdpi.com/1420-3049/25/12/2861/pdf